This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Monday, February 10, 2020, at 5:00 p.m. Eastern Time. The company…
DaVita is closing the decade by highlighting its milestones and achievements from 2019. Javier Rodriguez took the helm as CEO of DaVita Inc. on June 1, 2019. A DaVita teammate for more than 20…
DaVita Kidney Care today announced Dr. Jeffrey Giullian as chief medical officer (CMO). Dr. Giullian has most recently led clinical quality and safety efforts as CMO for DaVita Hospital Services,…
DaVita Inc. (NYSE: DVA) today announced results for the quarter ended September 30, 2019. Third quarter 2019 financial and operational highlights: Consolidated revenues of $2.904 billion….
DaVita Clinical Research (DCR) is set to present 10 research abstracts from company representatives and medical professionals at the American Society of Nephrology (ASN) annual Kidney Week in…